Cube Labs SpA
MIL:CUBE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cube Labs SpA
MIL:CUBE
|
IT |
|
Daetwyler Holding AG
SIX:DAE
|
CH |
|
Zehnder Group AG
SIX:ZEHN
|
CH |
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
CN |
|
SJVN Ltd
NSE:SJVN
|
IN |
|
D
|
D.M. Wenceslao & Associates Inc
XPHS:DMW
|
PH |
Income Statement
Earnings Waterfall
Cube Labs SpA
Income Statement
Cube Labs SpA
| Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
1
+22%
|
2
+28%
|
2
+15%
|
2
+12%
|
2
+19%
|
|
| Gross Profit | |||||||
| Cost of Revenue |
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Gross Profit |
0
N/A
|
(0)
N/A
|
(0)
-165%
|
(0)
+97%
|
0
N/A
|
1
+265%
|
|
| Operating Income | |||||||
| Operating Expenses |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
0
N/A
|
(0)
N/A
|
(1)
-114%
|
(1)
-25%
|
(1)
+1%
|
(0)
+67%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(1)
-459%
|
(1)
-80%
|
(1)
-20%
|
(1)
+10%
|
(0)
+61%
|
|
| Net Income | |||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
-444%
|
(1)
-74%
|
(1)
-19%
|
(1)
+11%
|
(0)
+63%
|
|
| EPS (Diluted) |
0
N/A
|
-0.02
N/A
|
-0.04
-100%
|
-0.05
-25%
|
-0.04
+20%
|
-0.01
+75%
|
|